The Colon Cancer Alliance thanks the following sponsors for their generous support in furthering our mission to end the suffering caused by colon cancer. Please contact Nicole Sheahan, Vice President of Development, if you would like to discuss becoming a sponsor to help us increase screening rates and survivorship by providing support, education, research and advocacy.

Special Thanks to Our Sponsors

Allsup is a nationwide provider of Social Security disability, veterans disability appeal, and Medicare and health insurance services. Allsup team members deliver specialized services supporting people with disabilities and seniors so they may lead lives that are as financially secure and as healthy as possible.
Amgen is a leading human therapeutics company in the biotechnology industry. For more than 25 years, the company has tapped the power of scientific discovery and innovation to advance the practice of medicine. Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or even save lives.
The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer, a subgroup of Bayer AG with annual sales of EUR 17.2 billion (2011), is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer’s aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide.
Biotechnology Industry Organization (BIO) is the world’s largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. Our mission is to be the champion of biotechnology and the advocate for our member organizations—both large and small.
Boston Scientific is a leading innovator of medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, Boston Scientific advances science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com.
Braintree Laboratories is a privately held pharmaceutical company founded in 1982 in Braintree, Massachusetts. Braintree Laboratories is a fully integrated specialty pharmaceutical company maintaining its own manufacturing, warehousing operations facilities, sales and marketing divisions and a pioneering research and development team.
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to extend and enhance human life by providing the highest-quality biopharmaceutical products. They are focused on both finding innovative medicines to combat serious diseases and on getting them to patients faster and more efficiently.
The Boehringer Ingelheim group*, the makers of Dulcolax, is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

*Dulcolax® products are marketed and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.

BTG is a growing international specialist healthcare company bringing to market innovative products in specialist areas of medicine to better serve doctors and their patients. We have a portfolio of Interventional Medicine products to advance the treatment of liver tumors, emphysema, blood clots, and varicose veins, and Specialty Pharmaceuticals that help patients overexposed to certain medications or toxins. Inspired by patient and physician needs, BTG is investing to expand its portfolio to address some of today’s most complex healthcare challenges. To learn more about BTG, please visit: btgplc.com.
Ethicon Endo-Surgery, Inc. (EES) works with clinicians from around the world to develop products that advance minimally invasive colorectal surgery. The goal is to provide better care for patients so they can return to their lives sooner, with less trauma and fewer complications.
Ferndale Healthcare®, Inc. is an affiliate of Ferndale Pharma Group Inc., a fully integrated holding company. Ferndale Healthcare® targets several key specialty markets which encompass disease states that range from benign anorectal disorders to various skin conditions. The company’s mission is to provide high-quality, value-added products that help patients get back to what matters most in their lives – living well. Many of Ferndale Healthcare’s products are leaders in their respective categories.
Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of gastroenterology, reproductive health, obstetrics, osteoarthritis and urology. To view all of our US offerings, please visit www.ferringusa.com.
Genentech BioOncology is an industry leader in researching the molecular basis of cancer with a long-standing commitment to fundamentally transforming the way cancer is treated. Genentech believes that studying the biological pathways involved in cancer development, progression and metastasis holds the key to identifying promising molecular targets. Genentech BioOncology is focused on both the basic biology of cancer and its application to therapeutics in oncology.
Genomic Health is a life science company founded in August of 2000 and located in Redwood City, California. It is committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-based clinical laboratory services. To that end, the company conducts sophisticated genomic research to develop new tools for diagnosis that provide individualized information on response to certain types of therapy, as well as the likelihood of disease recurrence. This is done through examining the behavior of multiple genes—a process known as genomic analysis— to provide patients and healthcare professionals with a better understanding of what is happening inside the patient’s tumor. These diagnostic technologies generate information that healthcare providers and patients can use in making treatment decisions.
H2ORS is an Oral Rehydration Solution (ORS), an electrolyte drink mix for dehydration, which is fully World Health Organization compliant and has a flavor profile that fits seamlessly in the American consumer market. ORS is proven to be as fast and effective for preventing and treating mild to moderate dehydration as IV fluids. Low-cost and over the counter, H2ORS is fast, effective, and reliable.
For more than four decades, Lilly Oncology, a division of Eli Lilly and Company, has been dedicated to delivering innovative solutions that improve the care of people living with cancer. Today, Lilly Oncology continues to place a priority on speeding innovation that will improve outcomes for individual patients facing cancer. And because no two cancer patients are alike, Lilly Oncology is committed to developing novel treatment approaches
The Medical Imaging & Technology Alliance (MITA), a division of the National Electrical Manufacturers Association (NEMA), is the collective voice of medical imaging equipment manufacturers, innovators, and product developers. It represents companies whose sales comprise more than 90 percent of the global market for medical imaging technology.
Myriad Genetics is dedicated to saving lives and improving the quality of life for patients worldwide through the discovery and commercialization of novel, transformative diagnostic products and services across major diseases.
Roche is an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases. They contribute on a broad range of fronts to improving people’s health and quality of life. Roche’s mission is to create added value in healthcare by focusing on diagnostics and pharmaceuticals.
Sanofi, a diversified global healthcare leader, discovers, develops, and distributes therapeutic solutions to improve the lives of everyone. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. At Sanofi, we work for what really matters: health.
Salix is committed to being the leading U.S. specialty pharmaceutical company licensing, developing and marketing innovative products to healthcare professionals to prevent or treat gastrointestinal disorders in patients while providing rewarding opportunities for our employees and creating exceptional value for our stockholders.
Sirtex Medical Limited is an Australian-based global healthcare business working to improve treatment outcomes in people with cancer. Our current lead product is a targeted radiation therapy for liver cancer called SIR-Spheres Y-90 resin microspheres. Approximately 50,000 doses have been supplied to treat patients with liver cancer at more than 800 medical centers in over 40 countries. Learn more at sirtex.com.
Taiho Oncology, Inc. works urgently to discover and develop innovative cancer treatments. As cancer evolves, we evolve with it—bringing novel technology to cornerstone chemotherapies, while at the same time optimizing new targeted agents. Advanced technology, dedicated investigators, and incomparable facilities—these vast resources empower us to redefine the way the world treats cancer.